Ion Pair Formation as a Possible Mechanism for the Enhancement Effect of Lauric Acid on the Transdermal Permeation of Ondansetron

References

• Elias P. M. Stratum corneum revisited. J. Dermatol. 1999; 23: 756–758
   Google Scholar
• Pfister W. R., Hsieh D. S.T. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations. Pharm. Technol. 1990; 14(9)132–139
   Google Scholar
• Llacer J. M., Gallardo V., Parera A., Ruiz M. A. Formation of ondansetron polymorphs. Int. J. Pharm. 1999; 177: 221–229
   PubMedGoogle Scholar
• Roila F., Favero D. A. Ondansetron clinical pharmacokinetics. Clin. Pharmacokinet. 1995; 29(2)95–109
   PubMed Web of Science ®Google Scholar
• Simpson K. H., Hicks F. M. Clinical pharmacokinetics of ondansetron. A review. J. Pharm. Pharmacol. 1996; 48: 774–781
   PubMed Web of Science ®Google Scholar
• Cothhup P. V., Felgate C. C., Palmer J. L., Scully N. L. Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly. J. Pharm. Sci. 1991; 80(9)868–871
   PubMed Web of Science ®Google Scholar
• Llacer J. M., Ruiz M. A., Parera A., Gallardo V. Adsortion–desorption of ondansetron on latex particles. Drug Dev. Ind. Pharm. 2000; 26(3)237–242
   PubMed Web of Science ®Google Scholar
• www.fda.gov/medwatch/safety/2000/dec00.htm, (accessed July 2002)
   Google Scholar
• Anderson P. O., Knoben J. E., Troutman W. G. Handbook of Clinical Drug Data. Appleton & Lange, Connecticut 1999; 519
   Google Scholar
• Dimas D. A., Dallas P. P., Rekkas D. M. Use of an 8132 asymmetrical factorial design for the in vitro evaluation of ondansetron permeation through human epidermis. Pharm. Dev. Technol., in press
   Google Scholar
• Walters K. A., Hadgraft J. Pharmaceutical Skin Penetration Enhancement. Marcel Dekker, New York 1993
   Google Scholar
• Quintanar‐Guerrero D., Allemann E., Fessi H., Doelker E. Applications of the ion‐pair concept to hydrophilic substances with special emphasis on peptides. Pharm. Res. 1997; 14(2)119–127
   PubMed Web of Science ®Google Scholar
• Lee S. J., Kurihara‐Bengstrom T., Kim S. W. Ion‐paired drug diffusion through polymer membranes. Int. J. Pharm. 1987; 47: 59–73
   Google Scholar
• The United States Pharmacopeia 24. United States Pharmacopeial Convention, Rockville, MD 2000; 1218–1220; 2231–2232
   Google Scholar
• Takahashi K., Rytting J. H. Approach to improve permeation of ondansetron across shed snake skin as a model membrane. J. Pharm. Pharmacol. 2001; 53: 789–794
   PubMed Web of Science ®Google Scholar
• Stott P. W., Williams A. C., Brian B. W. Mechanistic study into the enhanced transdermal permeation of a model b‐blocker, propanolol, by fatty acids: a melting point depression effect. Int. J. Pharm. 2001; 219: 161–176
   PubMed Web of Science ®Google Scholar
• Green P. G., Hadgraft J. Facilitated transfer of cationic drugs across a lipoidal membrane by oleic acid and lauric acid. Int. J. Pharm. 1987; 37: 251–255
   Web of Science ®Google Scholar
• Green P. G., Guy R. H., Hadgraft J. In vitro and in vivo enhancement of skin permeation with oleic lauric acids. Int. J. Pharm. 1988; 48: 103–111
   Google Scholar
• Barker N., Hadgraft J. Facilitated percutaneous absorption: a model system. Int. J. Pharm. 1981; 8: 193–202
   Google Scholar
• Hadgraft J., Walters K. A., Wotton R. K. Facilitated percutaneous absorption: a comparison and evaluation of two in vitro models. Int. J. Pharm. 1986; 32: 257–263
   Web of Science ®Google Scholar
• Green P. G., Hadgraft J., Wolff M. Physicochemical aspects of the transdermal delivery of bupranolol. Int. J. Pharm. 1989; 55: 259–265
   Google Scholar
• Pardo A., Shin Y., Cohen S. Kinetics of transdermal penetration of an organic ion pair: physostigmine salicylate. J. Pharm. Sci. 1992; 81: 990–995
   PubMed Web of Science ®Google Scholar
• Valenta C., Siman U., Kratzel M., Hadgraft J. The dermal delivery of lignocaine: influence of ion pairing. Int. J. Pharm. 2000; 197: 77–85
   PubMed Web of Science ®Google Scholar
• Hatanaka T., Kamon T., Morigaki S., Katayama K., Koizumi T. Ion pair skin transport of a zwitterionic drug, cephalexin. J. Control. Release 2000; 66: 63–71
   PubMed Web of Science ®Google Scholar
• Neubert R. Ion pair transport across membranes. Pharm. Res. 1989; 6(9)743–747
   PubMed Web of Science ®Google Scholar
• Ogiso T., Shintani M. Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propanolol. J. Pharm. Sci. 1990; 79(12)1065–1071
   PubMed Web of Science ®Google Scholar
• Dollimore D., Lerdkanchanaporn S. Thermal analysis. Anal. Chem. 1998; 70: 27R–35R
   Web of Science ®Google Scholar
• Stott P. W., Williams A. C., Barry B. W. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J. Control. Release 1998; 50: 297–308
   PubMed Web of Science ®Google Scholar
• Mahedran K. H., Nagaraj S., Sridharan R., Gnanasekaran T. Differential scanning calorimetric studies on the phase diagram of the binary LiCl–CaCl2 system. J. Alloys Compd. 2001; 325: 78–83
   Web of Science ®Google Scholar
• Ford J. A., Timmins P. Pharmaceutical Thermal Analysis. John Wiley & Sons, Inc., New York 1989; 25–68
   Google Scholar
• Touitou E., Chow D. D., Lawter J. R. Chiral b‐blockers for transdermal delivery. Int. J. Pharm. 1994; 104: 19–28
   Web of Science ®Google Scholar
• Rai U. S., George S. Thermochemical studies on the eutectics and addition compounds in the binary systems of benzidine with p‐nitrophenol, m‐aminophenol and resorcinol. Thermochim. Acta 1994; 243: 17–25
   Web of Science ®Google Scholar
• Rai U. S., Shekhar H. Some physicochemical studies on the binary organic eutectics. Thermochim. Acta 1991; 175: 215–227
   Web of Science ®Google Scholar
• Rai U. S., George S. Physicochemical studies on organic eutectics and the 1:1 addition compound: benzidine–α‐napthol system. J. Mater. Sci. 1992; 27: 17–25
   Web of Science ®Google Scholar